It's surprising how much pharmaceutical research to date has been more art than science. Computing power is still a long way off predicting the properties of proteins and cells from their DNA, so until then the more research that can be accelerated by automation (e.g. lab robots, lab-on-chip) the better.
And this is being driven by the big pharma companies who can't afford the failure rate at late stage drug development, or worse after release which can result in multi-billion law suits. I attended an excellenty talk by the chief scientific office for GE Healthcare recently and they are mass producing stem cell lines, and the machinery to test them, so that drugs can be tested for cardio-toxicity much earlier on in the development process.
Company with new approach to the treatment of autoimmune diseases.
Company discovering and developing innovative therapeutic and diagnostic solutions targeting liver diseases.
Company developing drugs for chronic medical conditions relating to abnormalities of bacterial composition.
Company developing and commercializing drugs for anti-aging applications capable of prolonging human health and life-span.
Company focused on development of therapeutics that slow the degenerative processes associated with aging.
Company for synthetic DNA production for specialty chemical compounds and drug development.
Japanese multinational pharmaceutical and biopharmaceutical company.
Pharmaceutical company focused on the development of novel drugs for the treatment of diabetes.
Biopharmaceutical company focused on the discovery and commercialization of novel therapies..
Fast generation of functional therapeutic antibodies.
Laboratory Automation Blog Posts
Automating healthy lifespan studies using nematodes
Kumamoto University - 28-Jan-2021
New automated system with AI searches genes, drugs to extend human healthy lifespanRead more...
Scientists manufactures artificial organoids using automation
Lab Manager - 11-Nov-2020
Semi-automating tissue differentiation makes artificial tissues at a faster rateRead more...
IBM develops an online chemistry lab 'RoboRXN'
MIT Technology Review - 28-Aug-2020
Will lower the cost & speed up the process of developing drugsRead more...